PMID- 22300722 OWN - NLM STAT- MEDLINE DCOM- 20120622 LR - 20220316 IS - 1873-2518 (Electronic) IS - 0264-410X (Linking) VI - 30 IP - 12 DP - 2012 Mar 9 TI - Immunogenicity study of plant-made oral subunit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV). PG - 2068-74 LID - 10.1016/j.vaccine.2012.01.059 [doi] AB - Currently, killed-virus and modified-live PRRSV vaccines are used to control porcine reproductive and respiratory syndrome disease (PRRS). However, very limited efficacy of killed-virus vaccines and serious safety concerns for modified-live virus vaccines demand the development of novel PRRSV vaccines. In this report, we investigated the possibility of using transgenic plants as a cost-effective and scalable system for production and delivery of a viral protein as an oral subunit vaccine against PRRSV. Corn calli were genetically engineered to produce PRRSV viral envelope-associated M protein. Both serum and intestine mucosal antigen-specific antibodies were induced by oral administration of the transgenic plant tissues to mice. In addition, serum and mucosal antibodies showed virus neutralization activity. The neutralization antibody titers after the final boost reached 6.7 in serum and 3.7 in fecal extracts, respectively. A PRRSV-specific IFN-gamma response was also detected in splenocytes of vaccinated animals. These results demonstrate that transgenic corn plants are an efficient subunit vaccine production and oral delivery system for generation of both systemic and mucosal immune responses against PRRSV. CI - Copyright A(c) 2012 Elsevier Ltd. All rights reserved. FAU - Hu, Jianzhong AU - Hu J AD - Department of Biological Systems Engineering, Virginia Tech, Blacksburg, VA 24061, USA. FAU - Ni, Yanyan AU - Ni Y FAU - Dryman, Barbara A AU - Dryman BA FAU - Meng, X J AU - Meng XJ FAU - Zhang, Chenming AU - Zhang C LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120131 PL - Netherlands TA - Vaccine JT - Vaccine JID - 8406899 RN - 0 (Antibodies, Neutralizing) RN - 0 (Antibodies, Viral) RN - 0 (M protein, porcine reproductive and respiratory syndrome virus) RN - 0 (Vaccines, Edible) RN - 0 (Vaccines, Subunit) RN - 0 (Vaccines, Synthetic) RN - 0 (Viral Matrix Proteins) RN - 0 (Viral Vaccines) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Administration, Oral MH - Animals MH - Antibodies, Neutralizing/analysis/blood MH - Antibodies, Viral/analysis/blood MH - Feces/chemistry MH - Female MH - Interferon-gamma/metabolism MH - Leukocytes, Mononuclear/immunology MH - Mice MH - Mice, Inbred BALB C MH - Mucous Membrane/immunology MH - Plants, Genetically Modified/*genetics MH - Porcine respiratory and reproductive syndrome virus/genetics/*immunology MH - Spleen/immunology MH - Vaccines, Edible/administration & dosage/genetics/immunology MH - Vaccines, Subunit/administration & dosage/genetics/immunology MH - Vaccines, Synthetic/administration & dosage/genetics/immunology MH - Viral Matrix Proteins/genetics/*immunology MH - Viral Vaccines/*administration & dosage/genetics/*immunology MH - Zea mays/genetics EDAT- 2012/02/04 06:00 MHDA- 2012/06/23 06:00 CRDT- 2012/02/04 06:00 PHST- 2011/12/01 00:00 [received] PHST- 2012/01/14 00:00 [revised] PHST- 2012/01/19 00:00 [accepted] PHST- 2012/02/04 06:00 [entrez] PHST- 2012/02/04 06:00 [pubmed] PHST- 2012/06/23 06:00 [medline] AID - S0264-410X(12)00097-7 [pii] AID - 10.1016/j.vaccine.2012.01.059 [doi] PST - ppublish SO - Vaccine. 2012 Mar 9;30(12):2068-74. doi: 10.1016/j.vaccine.2012.01.059. Epub 2012 Jan 31.